TY - JOUR
T1 - Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage
T2 - A Prospective Cohort Study
AU - Danino, Dana
AU - Ben-Shimol, Shalom
AU - Van Der Beek, Bart Adriaan
AU - Givon-Lavi, Noga
AU - Avni, Yonat Shemer
AU - Greenberg, David
AU - Weinberger, Daniel M.
AU - Dagan, Ron
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - Background: The incidence of invasive pneumococcal disease (IPD) declined during the COVID-19 pandemic. Previous studies hypothesized that this was due to reduced pneumococcal transmission resulting from nonpharmaceutical interventions. We used multiple ongoing cohort surveillance projects in children <5 years to test this hypothesis. Methods: The first SARS-CoV-2 cases were detected in February 2020, resulting in a full lockdown, followed by several partial restrictions. Data from ongoing surveillance projects captured the incidence dynamics of community-acquired alveolar pneumonia (CAAP), nonalveolar lower respiratory infections necessitating chest X-rays (NA-LRIs), nasopharyngeal pneumococcal carriage in nonrespiratory visits, nasopharyngeal respiratory virus detection (by polymerase chain reaction), and nationwide IPD. Monthly rates (January 2020 through February 2021 vs mean monthly rates 2016-2019 [expected rates]) adjusted for age and ethnicity were compared. Results: CAAP and bacteremic pneumococcal pneumonia were strongly reduced (incidence rate ratios [IRRs]:. 07 and. 19, respectively); NA-LRIs and nonpneumonia IPD were also reduced by a lesser magnitude (IRRs:. 46 and. 42, respectively). In contrast, pneumococcal carriage prevalence was only slightly reduced, and density of colonization and pneumococcal serotype distributions were similar to previous years. The decline in pneumococcus-associated disease was temporally associated with a full suppression of respiratory syncytial virus, influenza viruses, and human metapneumovirus, often implicated as co-pathogens with pneumococcus. In contrast, adenovirus, rhinovirus, and parainfluenza activities were within or above expected levels. Conclusions: Reductions in pneumococcal and pneumococcus-associated diseases occurring during the COVID-19 pandemic in Israel were not predominantly related to reduced pneumococcal carriage and density but were strongly associated with the disappearance of specific respiratory viruses.
AB - Background: The incidence of invasive pneumococcal disease (IPD) declined during the COVID-19 pandemic. Previous studies hypothesized that this was due to reduced pneumococcal transmission resulting from nonpharmaceutical interventions. We used multiple ongoing cohort surveillance projects in children <5 years to test this hypothesis. Methods: The first SARS-CoV-2 cases were detected in February 2020, resulting in a full lockdown, followed by several partial restrictions. Data from ongoing surveillance projects captured the incidence dynamics of community-acquired alveolar pneumonia (CAAP), nonalveolar lower respiratory infections necessitating chest X-rays (NA-LRIs), nasopharyngeal pneumococcal carriage in nonrespiratory visits, nasopharyngeal respiratory virus detection (by polymerase chain reaction), and nationwide IPD. Monthly rates (January 2020 through February 2021 vs mean monthly rates 2016-2019 [expected rates]) adjusted for age and ethnicity were compared. Results: CAAP and bacteremic pneumococcal pneumonia were strongly reduced (incidence rate ratios [IRRs]:. 07 and. 19, respectively); NA-LRIs and nonpneumonia IPD were also reduced by a lesser magnitude (IRRs:. 46 and. 42, respectively). In contrast, pneumococcal carriage prevalence was only slightly reduced, and density of colonization and pneumococcal serotype distributions were similar to previous years. The decline in pneumococcus-associated disease was temporally associated with a full suppression of respiratory syncytial virus, influenza viruses, and human metapneumovirus, often implicated as co-pathogens with pneumococcus. In contrast, adenovirus, rhinovirus, and parainfluenza activities were within or above expected levels. Conclusions: Reductions in pneumococcal and pneumococcus-associated diseases occurring during the COVID-19 pandemic in Israel were not predominantly related to reduced pneumococcal carriage and density but were strongly associated with the disappearance of specific respiratory viruses.
KW - COVID-19
KW - lower respiratory infections
KW - pneumococcal pneumoniae
KW - respiratory viruses
UR - http://www.scopus.com/inward/record.url?scp=85129662077&partnerID=8YFLogxK
U2 - 10.1093/cid/ciab1014
DO - 10.1093/cid/ciab1014
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34904635
AN - SCOPUS:85129662077
SN - 1058-4838
VL - 75
SP - E1154-E1164
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 1
ER -